These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4896)

  • 1. Reduction in myocardial infarct size: prevention of heart cell death.
    Kones RJ; Phillips JH
    South Med J; 1976 Apr; 69(4):442-8. PubMed ID: 4896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of infarct size following coronary occlusion.
    Braunwald E; Maroko PR; Libby P
    Circ Res; 1974 Sep; 35 Suppl 3():192-201. PubMed ID: 4606996
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of metabolic and pharmacologic interventions on myocardial infarct size following coronary occlusion.
    Maroko PR; Braunwald E
    Acta Med Scand Suppl; 1976; 587():125-36. PubMed ID: 3095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can infarct size be limited in patients with acute myocardial infarction?
    Muller JE; Braunwald E
    Cardiovasc Clin; 1983; 13(1):147-61. PubMed ID: 6129059
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of metabolic and pharmacologic interventions on myocardial infarct size following coronary occlusion.
    Maroko PR; Braunwald E
    Circulation; 1976 Mar; 53(3 Suppl):I162-8. PubMed ID: 767015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Protection for the ischemic myocardium: a transition between the experimental laboratory and medical practice].
    da Luz PL; Leite JJ; de Barros LF; Pileggi F
    Arq Bras Cardiol; 1980 Mar; 34(3):237-52. PubMed ID: 6108100
    [No Abstract]   [Full Text] [Related]  

  • 7. Limitation of myocardial infarct size. Present status.
    Yusuf S; Sleight P
    Drugs; 1983 May; 25(5):441-50. PubMed ID: 6134608
    [No Abstract]   [Full Text] [Related]  

  • 8. Myocardial infarct size. Part 2. Comparison of anti-infarct effects of beta-blockade, glucose-insulin-potassium, nitrates, and hyaluronidase.
    Opie LH
    Am Heart J; 1980 Oct; 100(4):531-52. PubMed ID: 6106384
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute myocardial infarction and muscle salvage: a potential role for pharmacological agents.
    Smith ER
    Can J Surg; 1974 Mar; 17(2):84-8. PubMed ID: 4150377
    [No Abstract]   [Full Text] [Related]  

  • 10. Modification of myocardial infarction size after coronary occlusion.
    Maroko PR; Braunwald E
    Ann Intern Med; 1973 Nov; 79(5):720-33. PubMed ID: 4148053
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacological salvage of myocardium.
    Lange LG; Sobel BE
    Annu Rev Pharmacol Toxicol; 1982; 22():115-43. PubMed ID: 6123293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of myocardial infarct size by early intervention.
    Danner SA
    Neth J Med; 1977; 20(3):107-15. PubMed ID: 18687
    [No Abstract]   [Full Text] [Related]  

  • 13. Pathophysiology of myocardial ischaemia and the prevention of necrosis.
    Taylor RR
    Clin Exp Pharmacol Physiol Suppl; 1982; 6():67-74. PubMed ID: 6126288
    [No Abstract]   [Full Text] [Related]  

  • 14. Investigations on protection of the ischemic myocardium.
    Braunwald E; Maroko PR
    Trans Am Clin Climatol Assoc; 1973; 84():80-115. PubMed ID: 4729259
    [No Abstract]   [Full Text] [Related]  

  • 15. [The development of ischemic damage to the myocardium and a review of methods which decrease it].
    Slezák J
    Bratisl Lek Listy; 1986 Mar; 85(3):345-62. PubMed ID: 3513913
    [No Abstract]   [Full Text] [Related]  

  • 16. The protective effect of trimetazidine on myocardial ischemia/reperfusion injury through activating AMPK and ERK signaling pathway.
    Liu Z; Chen JM; Huang H; Kuznicki M; Zheng S; Sun W; Quan N; Wang L; Yang H; Guo HM; Li J; Zhuang J; Zhu P
    Metabolism; 2016 Mar; 65(3):122-30. PubMed ID: 26892523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions for improving blood flow, oxygen availability and the balance between oxygen supply and demand in the acutely ischaemic myocardium.
    Parratt JR; Marshall RJ; Ledingham IM
    J Physiol (Paris); 1980; 76(7):791-803. PubMed ID: 6111608
    [No Abstract]   [Full Text] [Related]  

  • 18. [Measures to reduce infarct size (author's transl)].
    Zilcher H
    Wien Klin Wochenschr; 1979 Jan; 91(2):35-42. PubMed ID: 107658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reduction of the size of the acute myocardial infarct (AMI). Possibilities and limitations. Current status of the problem].
    Cosma M
    Rev Med Chir Soc Med Nat Iasi; 1978; 82(4):677-86. PubMed ID: 41300
    [No Abstract]   [Full Text] [Related]  

  • 20. Efforts to limit the size of myocardial infarcts.
    Rude RE; Muller JE; Braunwald E
    Ann Intern Med; 1981 Dec; 95(6):736-61. PubMed ID: 6118084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.